NDC 62175-330

Aspirin and Extended-Release Dipyridamole

Aspirin And Extended-release Dipyridamole

Aspirin and Extended-Release Dipyridamole is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Lannett Company, Inc.. The primary component is Aspirin; Dipyridamole.

• Product ID: 62175-330_0c0ece6d-5ce9-4da6-9482-2724772b61c8
• NDC: 62175-330
• Product Type: Human Prescription Drug
• Proprietary Name: Aspirin and Extended-Release Dipyridamole
• Generic Name: Aspirin And Extended-release Dipyridamole
• Dosage Form: Capsule, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2019-03-20
• Marketing Category: ANDA / ANDA
• Application Number: ANDA204552
• Labeler Name: Lannett Company, Inc.
• Substance Name: ASPIRIN; DIPYRIDAMOLE
• Active Ingredient Strength: 25 mg/1; mg/1
• Pharm Classes: Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 62175-330-35

60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62175-330-35)

• Marketing Start Date: 2019-03-20
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 62175-330-35 [62175033035]

Aspirin and Extended-Release Dipyridamole CAPSULE, EXTENDED RELEASE

• Marketing Category: ANDA
• Application Number: ANDA204552
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-03-20

Drug Details

Active Ingredients

Ingredient	Strength
ASPIRIN	25 mg/1

OpenFDA Data

• SPL SET ID: 1b1e6e68-343f-45ed-9956-870238303ead
• Manufacturer:
  • Lannett Company, Inc.
• UNII:
  • R16CO5Y76E
  • 64ALC7F90C
• RxNorm Concept Unique ID - RxCUI:
  • 259081
• Pharm Class PE:
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
• PHarm Class EPC:
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
• UPC Code:
  • 0362175330352
• NUI Code:
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

Pharmacological Class

• Cyclooxygenase Inhibitors [MoA]
• Decreased Prostaglandin Production [PE]
• Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
• Nonsteroidal Anti-inflammatory Drug [EPC]
• Platelet Aggregation Inhibitor [EPC]
• Decreased Platelet Aggregation [PE]
• Decreased Platelet Aggregation [PE]
• Platelet Aggregation Inhibitor [EPC]
• Anti-Inflammatory Agents
• Non-Steroidal [CS]

NDC Crossover Matching brand name "Aspirin and Extended-Release Dipyridamole" or generic name "Aspirin And Extended-release Dipyridamole"

NDC	Brand Name	Generic Name
42291-116	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
42571-274	ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE	ASPIRIN and Extended-Release DIPYRIDAMOLE
51407-271	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
60687-305	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
62175-330	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
62559-850	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
65162-596	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole